title: Yellow fever virus envelope protein expressed in insect cells is capable of syncytium formation in lepidopteran cells and could be used for immunodetection of YFV in human sera.
abstract: BACKGROUND
  Yellow fever is an haemorrhagic disease caused by a virus that belongs to the genus Flavivirus (Flaviviridae family) and is transmitted by mosquitoes. Among the viral proteins, the envelope protein (E) is the most studied one, due to its high antigenic potencial. Baculovirus are one of the most popular and efficient eukaryotic expression system. In this study a recombinant baculovirus (vSynYFE) containing the envelope gene (env) of the 17D vaccine strain of yellow fever virus was constructed and the recombinant protein antigenicity was tested.
  
  
  RESULTS
  Insect cells infected with vSynYFE showed syncytium formation, which is a cytopathic effect characteristic of flavivirus infection and expressed a polypeptide of around 54 kDa, which corresponds to the expected size of the recombinant E protein. Furthermore, the recombinant E protein expression was also confirmed by fluorescence microscopy of vSynYFE-infected insect cells. Total vSynYFE-infected insect extracts used as antigens detected the presence of antibodies for yellow fever virus in human sera derived from yellow fever-infected patients in an immunoassay and did not cross react with sera from dengue virus-infected patients.
  
  
  CONCLUSIONS
  The E protein expressed by the recombinant baculovirus in insect cells is antigenically similar to the wild protein and it may be useful for different medical applications, from improved diagnosis of the disease to source of antigens for the development of a subunit vaccine.
authors: Cell Biology Department, University of Brasília, Brasília, DF, CEP 70910-970, Brazil.
authors: Maria C E S
authors: MC
authors: Barros
authors: Tatiane G C M
authors: TG
authors: Galasso
authors: Antônio J M
authors: AJ
authors: Chaib
authors: Nicolas
authors: N
authors: Degallier
authors: Tatsuya
authors: T
authors: Nagata
authors: Bergmann M
authors: BM
authors: Ribeiro
references: J Gen Virol. 1991 Nov;72 ( Pt 11):2811-6
references: 1834798
references: Virol J. 2011 Mar 18;8:127
references: 21418577
references: Nat Biotechnol. 2005 May;23(5):567-75
references: 15877075
references: J Virol. 2003 Dec;77(23):12907-13
references: 14610213
references: Biologicals. 2010 Nov;38(6):613-8
references: 20817489
references: Ann Inst Pasteur Virol. 1988 Jan-Mar;139(1):59-67
references: 3061412
references: J Virol. 2007 Apr;81(7):3514-24
references: 17251294
references: J Gen Virol. 1991 Jun;72 ( Pt 6):1451-4
references: 1710651
references: J Med Chem. 2011 Mar 24;54(6):1704-14
references: 21355607
references: J Virol Methods. 2003 Jun 30;110(2):179-84
references: 12798246
references: J Virol. 1989 Oct;63(10):4199-209
references: 2674479
references: Virology. 1983 Feb;125(1):8-17
references: 6187129
references: J Virol Methods. 2000 Jul;88(1):63-71
references: 10921843
references: Bull Soc Pathol Exot. 2011 Oct;104(4):260-5
references: 21336654
references: Nature. 1970 Aug 15;227(5259):680-5
references: 5432063
references: Cell Biochem Biophys. 2006;44(3):313-24
references: 16679518
references: Clin Lab Med. 2010 Mar;30(1):237-60
references: 20513550
references: Braz J Infect Dis. 2004 Dec;8(6):390-8
references: 15880229
references: Rev Soc Bras Med Trop. 2003 Mar-Apr;36(2):275-93
references: 12806465
references: Epidemiol Infect. 2004 Oct;132(5):939-46
references: 15473158
references: Mol Biotechnol. 2000 Nov;16(3):193-202
references: 11252804
references: Virol J. 2010 Jun 29;7:143
references: 20587066
references: FEMS Immunol Med Microbiol. 2003 Nov 28;39(2):103-18
references: 14625093
references: Vaccine. 2010 Nov 29;28(51):8073-6
references: 20971115
references: N Engl J Med. 2011 Apr 7;364(14):1326-33
references: 21470010
references: Gene. 1991 Apr;100:131-7
references: 2055465
references: Clin Infect Dis. 2007 Mar 15;44(6):850-6
references: 17304460
references: Annu Rev Entomol. 1999;44:257-89
references: 15012374